A spirometer is used to help a patient who is having difficulties breathing and is not getting enough oxygen. Patients with respiratory illnesses such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and acute respiratory distress syndrome also require COPD and asthma diagnostic and monitoring devices. Furthermore, an increase in the elderly population, cigarette smoking, allergens, and air pollution raise the prevalence of respiratory disorders, driving the worldwide spirometer market.
The global spirometer market is estimated to be valued at US$ 958.0 million in 2021 and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028).
The global spirometer market is expected to expand during the projected period due to factors such as innovation, technological advances, and spirometer upgrades. According to the World Health Organization (WHO), asthma affects around 300 million people worldwide, and 250,000 people have died as a result of asthma. In 2019, around 65 million individuals worldwide have COPD, with approximately 16 million Americans having COPD, and the figure is expected to rise in the future. Spirometers are widely used in the treatment, diagnosis, monitoring, and management of respiratory illnesses. The key reasons driving the spirometer market expansion are an increase in the incidence of respiratory disorders and an increase in the adoption of smoking and alcohol intake.
On the basis of type, the table-top segment is estimated to garner largest share during the forecast period. This segment is expected to maintain its dominant position throughout the forecast period. Moreover, innovations in diagnostic devices have not only made it convenient to use them, but also made them portable and automatic. Furthermore, these advancements help clinical researchers and physicians in investigational studies. All these factors are expected to propel the growth of the market during the forecast period.
On the basis of technology, the flow measurement segment accounted for the largest share in 2019. This is attributed to the increasing use of flow measurement spirometer in pulmonary function testing applications for clinical diagnosis of COPD and asthma. These are smaller and portable, computerized and also help in minimizing infections. Thus, flow measurement technology is more desirable than spirometers with volume measurement technology and are expected to grow at the highest CAGR over the analysis period.
No comments:
Post a Comment